Company intelligence / Profile preview

Beijing Huaxin Biological Technology

Beijing, Beijing, China

Ownership: Private
Employees: ~200
Development stage: Other

Overview

Beijing Huaxin Biological Technology is a Chinese biopharmaceutical company dedicated to the research, development, and large-scale production of human vaccines. The company is a prominent provider of rabies vaccines (Vero cell) in the domestic market, utilizing advanced cell culture techniques to ensure product safety and efficacy. Huaxin Bio's strategic focus encompasses the prevention of infectious diseases through a portfolio of viral vaccines and biological products. With established GMP-certified manufacturing capabilities in Beijing, the company serves as a key contributor to China's public health infrastructure.

Therapeutic areas: Infectious Diseases
Modalities: VaccineBiologic
Industry: Pharma

Beyond the preview

Go deeper on Beijing Huaxin Biological Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beijing Huaxin Biological Technology.

Explore the full profile